Principal Scientist
Merck & Co., Inc.
Marina Ichetovkin, MS, Principal Scientist at Merck and Co., has 20 years of drug discovery experience in oncology and metabolic diseases. For the last 8 years, Marina has been overseeing immunoassay based bioanalysis of biotherapeutics, PK, ADA, and NAb assays. Highlights of her career include contributions to development of Nexavar (sorafenib) and Zinplava (bezlotoxumab).
Marina received a BS degree in Forensic Science from John Jay College of Criminal Justice and MS in Biomedical Sciences from Albert Einstein College of Medicine, Sue Golding Graduate Division.